Clinical Trial Update: Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating apixaban for the prevention of thrombosis-related events in patients with acute medical illness has completed and posted results in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thrombosis, Pulmonary Embolism | Phase 3 | Status: COMPLETED | Results posted: 2014-05-20